Inventiva S.A. | Mid-cap | Healthcare
€3.88
-0.39%
| Inventiva S.A Stock Comparison:
Inventiva S.A vs Abivax SAInventiva S.A vs Valneva SEInventiva S.A vs Medincell S.AInventiva S.A vs BNP Paribas EasyInventiva S.A vs NanobiotixInventiva S.A vs CAC 40 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2021

Income Metrics

Revenue 65.0K
Operating Income -13.7M -21,032.31%
Net Income -14.3M -21,992.31%
EPS (Diluted) €-0.37

Balance Sheet Metrics

Total Assets 119.0M
Total Liabilities 225.6M
Shareholders Equity -106.6M

Cash Flow Metrics

Operating Cash Flow -24.5M
Free Cash Flow -12.1M

Revenue & Profitability Trend

Inventiva S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i9.2M17.5M12.2M4.2M372.0K
Cost of Goods Sold i-----
Gross Profit i-----
Gross Margin % i0.0%0.0%0.0%0.0%0.0%
Operating Expenses
Research & Development i90.9M110.0M60.5M48.5M23.7M
Selling, General & Administrative i17.1M15.6M15.3M11.3M8.9M
Other Operating Expenses i-5.5M-5.7M-6.9M-6.5M-3.0M
Total Operating Expenses i102.5M119.9M68.8M53.3M29.6M
Operating Income i-94.0M-102.7M-56.9M-51.2M-26.5M
Operating Margin % i-1,021.8%-587.4%-466.8%-1,220.2%-7,136.0%
Non-Operating Items
Interest Income i1.1M991.0K390.0K57.0K226.0K
Interest Expense i12.2M5.2M707.0K138.0K66.0K
Other Non-Operating Income-78.8M-2.9M2.9M2.0M-7.2M
Pre-tax Income i-183.9M-109.8M-54.3M-49.3M-33.6M
Income Tax i313.0K607.0K-20.0K364.0K0
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-184.2M-110.4M-54.3M-49.6M-33.6M
Net Margin % i-2,002.8%-631.8%-445.6%-1,183.6%-9,037.1%
Key Metrics
EBITDA i-88.0M-101.1M-54.8M-50.9M-24.4M
EPS (Basic) i€-3.08€-2.43€-1.31€-1.27€-0.99
EPS (Diluted) i€-3.08€-2.43€-1.31€-1.27€-0.99
Basic Shares Outstanding i5977870145351799414497323916815233874751
Diluted Shares Outstanding i5977870145351799414497323916815233874751

Income Statement Trend

Inventiva S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i96.6M26.9M86.7M86.6M105.7M
Short-term Investments i070.0K1.0M8.8M7.3M
Accounts Receivable i531.0K3.8M04.0M48.0K
Inventory i0417.0K373.0K392.0K320.0K
Other Current Assets349.0K422.0K282.0K763.0K1.0M
Total Current Assets i111.5M48.2M106.4M115.6M133.0M
Non-Current Assets
Property, Plant & Equipment i10.7M10.5M6.8M1.6M1.2M
Goodwill i48.0K542.0K568.0K770.0K935.0K
Intangible Assets i48.0K542.0K568.0K770.0K935.0K
Long-term Investments-----
Other Non-Current Assets217.0K225.0K65.0K-2.0K-
Total Non-Current Assets i7.5M21.4M9.6M6.4M5.9M
Total Assets i119.0M69.6M116.0M122.0M138.9M
Liabilities
Current Liabilities
Accounts Payable i32.9M37.7M19.4M14.6M6.9M
Short-term Debt i5.9M5.3M5.9M1.3M18.0K
Current Portion of Long-term Debt-----
Other Current Liabilities73.4M--1.0K1.0K-
Total Current Liabilities i120.7M50.2M30.7M22.9M13.9M
Non-Current Liabilities
Long-term Debt i48.5M32.2M28.7M8.8M10.0M
Deferred Tax Liabilities i-----
Other Non-Current Liabilities30.2M7.4M-2.0K-2.0K1.0K
Total Non-Current Liabilities i104.9M51.4M39.8M10.3M13.8M
Total Liabilities i225.6M101.6M70.5M33.1M27.7M
Equity
Common Stock i957.0K521.0K421.0K409.0K386.0K
Retained Earnings i-184.2M-110.4M-54.3M-49.6M-33.6M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i-106.6M-32.0M45.5M88.9M111.2M
Key Metrics
Total Debt i54.3M37.5M34.5M10.1M10.1M
Working Capital i-9.2M-2.0M75.7M92.7M119.1M

Balance Sheet Composition

Inventiva S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-184.2M-110.4M-54.3M-49.6M-33.6M
Depreciation & Amortization i5.2M2.6M1.7M-1.3M1.9M
Stock-Based Compensation i3.6M4.0M2.2M2.1M938.0K
Working Capital Changes i5.0M-2.7M2.2M-6.6M-3.2M
Operating Cash Flow i-87.4M-109.1M-52.4M-58.0M-43.3M
Investing Activities
Capital Expenditures i-333.0K-409.0K-520.0K-445.0K-292.0K
Acquisitions i-----
Investment Purchases i--8.3M-1.0K-1.3M-8.3M
Investment Sales i9.1M978.0K9.4M--
Investing Cash Flow i8.7M-7.7M8.9M-1.8M-8.6M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i24.9M030.2M010.0M
Debt Repayment i-5.0M-4.1M-1.8M-28.0K-87.0K
Financing Cash Flow i87.4M29.1M67.5M25.4M121.7M
Free Cash Flow i-86.3M-82.2M-45.5M-48.2M-30.9M
Net Change in Cash i8.7M-87.8M24.0M-34.3M69.8M

Cash Flow Trend

Inventiva S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -1.25
Forward P/E -2.75
Price to Book -1.40
Price to Sales 38.04
PEG Ratio -2.75

Profitability Ratios

Profit Margin 0.00%
Operating Margin -384.43%
Return on Equity 172.73%
Return on Assets -63.60%

Financial Health

Current Ratio 0.92
Debt to Equity -1.70
Beta 0.62

Per Share Data

EPS (TTM) €-3.08
Book Value per Share €-1.12
Revenue per Share €0.24

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
iva536.1M-1.25-1.40172.73%0.00%-1.70
Abivax SA 5.0B-23.91-639.37-196.12%0.00%-16.16
Valneva SE 857.1M70.644.50-38.02%-34.15%105.63
Medincell S.A 584.8M--112.65%-66.50%-4.11
BNP Paribas Easy 463.1M15.99--96.39%-27.22%2.22
Nanobiotix 360.4M-5.10-103.70%0.00%-0.77

Financial data is updated regularly. All figures are in the company's reporting currency.